Article Image

Bio-Gene Technology (ASX:BGT) receives US patent approval for insect control

Bio-Gene Technology (ASX:BGT) has announced the allowance of a US patent application by the United States Patent Office, which relates to the use of the company's molecules to control resistant pests.

The patent will extend the patent protection for Bio-Gene’s technology to 2038, and further supports its core value proposition.

Bio-Gene says it's continuing to develop commercial applications for its products and is currently examining additional patent applications relating to control of resistant pests.

 

 

More stories from Grafa
Check out other news relating to this publisher